CME Group Stock Price, News & Analysis (NASDAQ:CME)

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a quarterly dividend on Wednesday, August 7th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share on Wednesday, September 25th. This represents a $3.00 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, September 9th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings results on Wednesday, July, 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.75 by $0.01. The financial services provider had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group's revenue was up 20.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.74 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for CME Group.

CME Group will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

14 equities research analysts have issued 1-year target prices for CME Group's stock. Their forecasts range from $150.00 to $240.00. On average, they anticipate CME Group's stock price to reach $203.2308 in the next year. This suggests that the stock has a possible downside of 3.8%. View Analyst Price Targets for CME Group.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CME Group.

News coverage about CME stock has been trending somewhat negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CME Group earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned press coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for CME Group.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), DEUTSCHE BOERSE/ADR (DBOEY), T. Rowe Price Group (TROW), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), OTC Markets Group (OTCM), Yintech Investment (YIN), National (NHLD) and Primus Guaranty (PRSG).

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Paypal (PYPL), Boeing (BA), Netflix (NFLX), Mastercard (MA), Visa (V), Intel (INTC), Bank of America (BAC), Home Depot (HD) and Walt Disney (DIS).

CME Group's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.84%), BlackRock Inc. (6.65%), BlackRock Inc. (6.63%), Edgewood Management LLC (2.11%), Janus Henderson Group PLC (1.54%) and Northern Trust Corp (1.18%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Quest Capital Management Inc. ADV, Mizuho Bank Ltd., Renaissance Technologies LLC, Janus Henderson Group PLC, Point72 Asset Management L.P., AQR Capital Management LLC and Vontobel Asset Management Inc.. Company insiders that have sold CME Group company stock in the last year include Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Parnassus Investments CA, Magellan Asset Management Ltd, Fiera Capital Corp, Amundi Pioneer Asset Management Inc., AKO Capital LLP, Vanguard Group Inc. and Sarasin & Partners LLP. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $211.15.

CME Group has a market capitalization of $75.61 billion and generates $4.31 billion in revenue each year. The financial services provider earns $1.96 billion in net income (profit) each year or $6.82 on an earnings per share basis. CME Group employs 4,590 workers across the globe.View Additional Information About CME Group.

The official website for CME Group is http://www.cmegroup.com/.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]